摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-(2-(2-(2-(1H-imidazole-1-carbonyloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl 1H-imidazole-1-carboxylate | 1257408-26-6

中文名称
——
中文别名
——
英文名称
2-(2-(2-(2-(2-(1H-imidazole-1-carbonyloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl 1H-imidazole-1-carboxylate
英文别名
——
2-(2-(2-(2-(2-(1H-imidazole-1-carbonyloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl 1H-imidazole-1-carboxylate化学式
CAS
1257408-26-6
化学式
C24H38N4O11
mdl
——
分子量
558.586
InChiKey
GPIVCMSICFVUNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.87
  • 重原子数:
    39.0
  • 可旋转键数:
    24.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    152.85
  • 氢给体数:
    0.0
  • 氢受体数:
    15.0

反应信息

  • 作为反应物:
    描述:
    IAC 、 2-(2-(2-(2-(2-(1H-imidazole-1-carbonyloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl 1H-imidazole-1-carboxylateN,N-二异丙基乙胺 作用下, 以 二甲基亚砜 为溶剂, 反应 0.5h, 以55%的产率得到(2S)-2-[2-[[3-[2-[2-[2-[2-[2-[2-[2-[2-[[3-[2-[[(1S)-1-carboxy-2-[[4-[2-(1,4,5,6-tetrahydropyrimidin-2-ylamino)ethoxy]benzoyl]amino]ethyl]sulfamoyl]ethylcarbamoyloxy]-2,2-dimethylpropyl]carbamoyloxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxycarbonylamino]-2,2-dimethylpropoxy]carbonylamino]ethylsulfonylamino]-3-[[4-[2-(1,4,5,6-tetrahydropyrimidin-2-ylamino)ethoxy]benzoyl]amino]propanoic acid
    参考文献:
    名称:
    Synthesis and evaluation of bivalent, peptidomimetic antagonists of the αvβ3 integrins
    摘要:
    Targeting the integrin alpha(v)beta(3) by directly interfering with its function is considered to be an effective and non-cytotoxic strategy for the treatment of tumor. In this study, a series of bivalent analogs of peptidomimetic integrin antagonists IA 1 and IAC 2 were designed, synthesized, and evaluated for their ability to inhibit the integrin alpha(v)beta(3). All the bivalent ligands exhibited increased potency compared to that of their monomeric counterparts for the integrin alpha(v)beta(3) with low nanomolar range binding affinity. The best bivalent ligand 6 tested in the series has an IC50 = 0.09 nM evaluated by ELISA assay. We conclude that multivalency is providing a useful template for the development novel integrin alpha(v)beta(3) antagonists as potential therapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.035
  • 作为产物:
    描述:
    八乙二醇N,N'-羰基二咪唑N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 6.0h, 以80%的产率得到2-(2-(2-(2-(2-(1H-imidazole-1-carbonyloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl 1H-imidazole-1-carboxylate
    参考文献:
    名称:
    Synthesis and evaluation of bivalent, peptidomimetic antagonists of the αvβ3 integrins
    摘要:
    Targeting the integrin alpha(v)beta(3) by directly interfering with its function is considered to be an effective and non-cytotoxic strategy for the treatment of tumor. In this study, a series of bivalent analogs of peptidomimetic integrin antagonists IA 1 and IAC 2 were designed, synthesized, and evaluated for their ability to inhibit the integrin alpha(v)beta(3). All the bivalent ligands exhibited increased potency compared to that of their monomeric counterparts for the integrin alpha(v)beta(3) with low nanomolar range binding affinity. The best bivalent ligand 6 tested in the series has an IC50 = 0.09 nM evaluated by ELISA assay. We conclude that multivalency is providing a useful template for the development novel integrin alpha(v)beta(3) antagonists as potential therapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.09.035
点击查看最新优质反应信息